A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer

Future Oncology
Kathleen N MooreMichael J Birrer

Abstract

Resistance to platinum-based therapy poses a significant clinical challenge for the management of advanced ovarian cancer, a leading cause of cancer mortality among women. Mirvetuximab soravtansine is a novel antibody-drug conjugate that targets folate receptor-α, a validated molecular target for therapeutic intervention in this disease. Here, we examine mirvetuximab soravtansine's mechanism of action and pharmacology, and review its clinical evaluation in ovarian cancer to date. We focus on the favorable tolerability and encouraging signals of efficacy that have emerged, most notably in patients with platinum-resistant disease. Ongoing Phase III monotherapy and Phase Ib/II combination trials evaluating its activity in the setting of platinum resistance are emphasized, which will help define its role in the evolving landscape of ovarian cancer therapy.

References

Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P G RoseM Rodriguez
May 16, 1998·International Journal of Cancer. Journal International Du Cancer·G ToffoliM Boiocchi
Mar 8, 2000·The Oncologist·M Markman, M A Bookman
Mar 17, 2000·The Journal of Nutrition·S W Choi, J B Mason
Jul 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A N GordonA J Lacave
Apr 20, 2004·Advanced Drug Delivery Reviews·Hala Elnakat, Manohar Ratnam
Mar 3, 2007·Cancer Metastasis Reviews·Marcela D'Alincourt Salazar, Manohar Ratnam
Jan 29, 2008·Gynecologic Oncology·Kimberly R KalliLynn C Hartmann
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gabriella FerrandinaGiovanni Scambia
Jun 5, 2008·Cancer Metastasis Reviews·Emanuela I Sega, Philip S Low
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A BookmanLawrence M Roth
Jan 23, 2010·Expert Opinion on Biological Therapy·Whitney A SpannuthRobert L Coleman
Sep 22, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jason A KonnerLloyd J Old
Oct 13, 2010·Molecular Cancer Therapeutics·Emin OroudjevMary Ann Jordan
May 6, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Gavin C E StuartUNKNOWN Gynecologic Cancer Intergroup
May 17, 2011·Annual Review of Nutrition·Rongbao ZhaoI David Goldman
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jul 12, 2011·The Lancet Oncology·Susanna L Cooke, James D Brenton
Sep 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Susana Banerjee, Stan Kaye
Sep 8, 2012·Cancer Biology & Therapy·Sita Kugel DesmoulinLarry H Matherly
Oct 9, 2012·Drug Development and Industrial Pharmacy·Madhushree GokhaleFrank Rinaldi
Nov 24, 2012·British Journal of Clinical Pharmacology·John M Lambert
Mar 23, 2013·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Daniel J O'ShannessyYao-Shi Fu
Oct 16, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R Wendel NaumannRichard A Messmann
Nov 19, 2013·Gynecologic Oncology·Thomas J HerzogRonald D Alvarez
Mar 13, 2014·Gynecologic Oncology·Alison DavisMichael Friedlander
Mar 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Pujade-LauraineIsabelle Ray-Coquard
Mar 29, 2014·Angewandte Chemie·Ravi V J ChariWayne C Widdison
Apr 20, 2014·Expert Review of Clinical Pharmacology·Allison J AmbrosioRichard T Penson
May 28, 2014·Journal of Ovarian Research·Gerasimos Aravantinos, Dimitrios Pectasides
Jul 18, 2014·OncoTargets and Therapy·Claudia MarchettiPierluigi Benedetti Panici
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Oct 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joyce Liu, Ursula A Matulonis
Oct 25, 2014·Therapeutic Advances in Medical Oncology·Daniela LuveroJonathan A Ledermann
Dec 3, 2014·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Yehuda G AssarafJoseph A Reddy
Dec 11, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Hongye YeXian Jun Loh
Dec 20, 2014·World Journal of Translational Medicine·Arpita DesaiVeena N Rao
Jan 6, 2015·Chinese Journal of Cancer·Chiara Della PepaSando Pignata
Jan 8, 2015·Cancer Metastasis Reviews·Ignace B VergoteRobert L Coleman
Feb 12, 2015·PloS One·Victor S GoldmacherYelena V Kovtun
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators

❮ Previous
Next ❯

Citations

Dec 12, 2018·Current Opinion in Obstetrics & Gynecology·Daphne Stewart, Mihaela Cristea
May 18, 2019·CA: a Cancer Journal for Clinicians·Stephanie LheureuxAmit M Oza
Mar 13, 2019·Journal of the National Cancer Institute·Michael J BirrerRichard C Bates
Jan 13, 2019·The Oncologist·Michael J BirrerKathleen N Moore
Sep 5, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lianqiao QiaoXiaowei Xi
May 29, 2020·Expert Opinion on Biological Therapy·Corinne A Calo, David M O'Malley
May 14, 2020·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Fu XiaomengYuan Dandan
Jul 22, 2018·International Journal of Molecular Sciences·Andrea RizzoDelia Mezzanzanica
Dec 26, 2018·Clinical Kidney Journal·Thomas WeimbsBryan C Bourgeois
Jul 31, 2020·Signal Transduction and Targeted Therapy·Qiao WangXia Zhao
Mar 15, 2019·Journal of Experimental & Clinical Cancer Research : CR·Barbara FrigerioMariangela Figini
Oct 12, 2019·Journal of Ovarian Research·Zi-Hui ZhengJun Lu
Oct 22, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Umbreen HafeezAndrew M Scott
Nov 11, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ursula A MatulonisStella K Kim
Oct 19, 2020·International Journal of Pharmaceutics·Yuan LiHuile Gao
Nov 1, 2018·Cornea·Eleonora CorbelliGiulio Maria Modorati
Mar 6, 2021·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K N MooreM J Birrer
Jun 15, 2021·Current Oncology Reports·David M O'Malley, Corinne A Calo
Jul 30, 2019·Molecular Pharmaceutics·Haiyan ChuChristopher P Leamon
Jan 17, 2021·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Patrycja GuzikCristina Müller

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
xenografts
biopsy

Clinical Trials Mentioned

NCT01609556
NCT02631876
NCT02606305

Software Mentioned

FORWARD

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Yoshitaka OnishiMasayuki Hatae
American Journal of Obstetrics and Gynecology
Thomas C KrivakRichard G Moore
Annals of Oncology : Official Journal of the European Society for Medical Oncology
E GalligioniC Griso
© 2022 Meta ULC. All rights reserved